6-166412777-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BS1BS2
The ENST00000265678.9(RPS6KA2):āc.2187G>Cā(p.Thr729=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00227 in 1,598,718 control chromosomes in the GnomAD database, including 80 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ).
Frequency
Genomes: š 0.011 ( 42 hom., cov: 35)
Exomes š: 0.0013 ( 38 hom. )
Consequence
RPS6KA2
ENST00000265678.9 synonymous
ENST00000265678.9 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.793
Genes affected
RPS6KA2 (HGNC:10431): (ribosomal protein S6 kinase A2) This gene encodes a member of the RSK (ribosomal S6 kinase) family of serine/threonine kinases. This kinase contains two non-identical kinase catalytic domains and phosphorylates various substrates, including members of the mitogen-activated kinase (MAPK) signalling pathway. The activity of this protein has been implicated in controlling cell growth and differentiation. Alternative splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 6-166412777-C-G is Benign according to our data. Variant chr6-166412777-C-G is described in ClinVar as [Benign]. Clinvar id is 781018.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.793 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0112 (1711/152320) while in subpopulation AFR AF= 0.0386 (1605/41580). AF 95% confidence interval is 0.037. There are 42 homozygotes in gnomad4. There are 827 alleles in male gnomad4 subpopulation. Median coverage is 35. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1711 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPS6KA2 | NM_021135.6 | c.2187G>C | p.Thr729= | synonymous_variant | 21/21 | ENST00000265678.9 | NP_066958.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPS6KA2 | ENST00000265678.9 | c.2187G>C | p.Thr729= | synonymous_variant | 21/21 | 1 | NM_021135.6 | ENSP00000265678 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0111 AC: 1695AN: 152202Hom.: 42 Cov.: 35
GnomAD3 genomes
AF:
AC:
1695
AN:
152202
Hom.:
Cov.:
35
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00279 AC: 619AN: 221642Hom.: 8 AF XY: 0.00206 AC XY: 246AN XY: 119684
GnomAD3 exomes
AF:
AC:
619
AN:
221642
Hom.:
AF XY:
AC XY:
246
AN XY:
119684
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00132 AC: 1914AN: 1446398Hom.: 38 Cov.: 40 AF XY: 0.00115 AC XY: 828AN XY: 717942
GnomAD4 exome
AF:
AC:
1914
AN:
1446398
Hom.:
Cov.:
40
AF XY:
AC XY:
828
AN XY:
717942
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0112 AC: 1711AN: 152320Hom.: 42 Cov.: 35 AF XY: 0.0111 AC XY: 827AN XY: 74482
GnomAD4 genome
AF:
AC:
1711
AN:
152320
Hom.:
Cov.:
35
AF XY:
AC XY:
827
AN XY:
74482
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
18
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 13, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at